ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default 登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。
Intersect ENT Inc

Intersect ENT Inc (XENT)

28.25
0.00
(0.00%)
終了 1月28日 6:00AM
28.25
0.00
( 0.00% )
プレマーケット: 9:00AM

個人投資家向けのプロ仕様のツール。

主要統計と詳細

通貨
28.25
買値
28.16
売値
28.36
出来高
-
0.00 日の範囲 0.00
0.00 52 週間の範囲 0.00
前日終値
28.25
始値
-
時刻
最終取引時間
-
平均取引量 (3 か月)
-
財務取引量
-
VWAP
-

XENT 最新ニュース

Real-World Evidence Study Demonstrates Intersect ENT’s PROPEL® Sinus Implant Reduces Healthcare Resource Utilization

Data from first-of-its-kind study published in Current Medical Research and Opinion Patients receiving PROPEL® following endoscopic sinus surgery had statistically significant lower healthcare...

Intersect ENT Reports Third Quarter 2021 Financial Results

Intersect ENT, Inc. (Nasdaq: XENT), a global ear, nose and throat (“ENT”) medical technology leader dedicated to transforming patient care, today reported financial results for the third quarter...

First Implants of PROPEL® Contour in Patients with Chronic Rhinosinusitis Following Frontal Sinus Surgery in Europe

Intersect ENT®, Inc. (Nasdaq: XENT), a global ear, nose and throat (“ENT”) medical technology leader dedicated to transforming patient care, today announced that Helios Dr. Horst Schmidt Kliniken...

ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Intersect ENT, Inc.

ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Intersect ENT, Inc. PR Newswire NEW YORK, Aug. 9, 2021 NEW YORK, Aug. 9, 2021 /PRNewswire/ -- Rowley Law PLLC is investigating...

Intersect ENT Reports Second Quarter 2021 Financial Results

Intersect ENT, Inc. (Nasdaq: XENT), a global ear, nose and throat (“ENT”) medical technology leader dedicated to transforming patient care, today reported financial results for the second quarter...

Medtronic to Acquire Intersect ENT

Medtronic to Acquire Intersect ENT Acquisition to Add Innovative Bioabsorbable Drug Release Platform to Chronic Rhinosinusitis Portfolio PR Newswire DUBLIN and MENLO PARK, Calif., Aug. 6, 2021...

U.S Nationwide Commercial Availability of the VenSure™ Balloon Sinus Dilation System and Cube™ Navigation System Highlight Intersect ENT’s Continued Commitment to Providing Innovative, Solutions for Patients with Chronic Rhinosinusitis

VenSure and Cube Join the Company’s Portfolio of Localized Drug Delivery Creating an Integrated Offering of ENT Technologies to Treat CRS Intersect ENT®, Inc. (Nasdaq: XENT), a global ear, nose...

Intersect ENT to Report Second Quarter 2021 Financial Results on August 6

Intersect ENT, Inc. (Nasdaq: XENT), a global ear, nose and throat (“ENT”) medical technology leader dedicated to transforming patient care, today announced that it will release second quarter...

Intersect ENT Announces Preliminary Revenue for Second Quarter of 2021 and Closing of $60 Million Term Loan

Intersect ENT, Inc. (Nasdaq: XENT), a global ear, nose and throat (“ENT”) medical technology leader dedicated to transforming patient care, today announced preliminary second quarter 2021 revenue...

Intersect ENT Receives CE Mark Approval for PROPEL® Contour for Patients with Chronic Rhinosinusitis Following Frontal Sinus...

Localized steroid-releasing sinus implant designed to maintain sinus opening now available in select EU countries Intersect ENT®, Inc. (Nasdaq: XENT), a global ear, nose and throat (“ENT”...

期間 †前日比前日比 %始値高値安値平均出来高VWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

XENT - Frequently Asked Questions (FAQ)

What is the current Intersect ENT share price?
The current share price of Intersect ENT is US$ 28.25
What is the 1 year trading range for Intersect ENT share price?
Intersect ENT has traded in the range of US$ 0.00 to US$ 0.00 during the past year

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
YIBOPlanet Image International Ltd
US$ 5.55
(80.19%)
24.15M
SLXNSilexion Therapeutics Corporation
US$ 1.04
(79.31%)
22.76M
BACKIMAC Holdings Inc
US$ 1.4099
(70.07%)
34.4M
TRIBTrinity Biotech PLC
US$ 1.28
(68.42%)
51.45M
FORLFour Leaf Acquisition Corporation
US$ 17.91
(60.20%)
12
LPTXLeap Therapeutics Inc
US$ 0.85
(-62.22%)
1.64M
STSSSharps Technology Inc
US$ 0.5702
(-60.95%)
816.3k
TMCITreace Medical Concepts Inc
US$ 4.00
(-58.76%)
200
HCVIHennessy Capital Investment Corporation VI
US$ 6.01
(-43.89%)
9
CCECCapital Clean Energy Carriers Corporation
US$ 13.01
(-29.68%)
13
TRIBTrinity Biotech PLC
US$ 1.28
(68.42%)
51.47M
BACKIMAC Holdings Inc
US$ 1.41
(70.08%)
34.41M
HEPAHepion Pharmaceuticals Inc
US$ 0.2004
(21.45%)
33.53M
NVDANVIDIA Corporation
US$ 121.89
(2.93%)
25.63M
YIBOPlanet Image International Ltd
US$ 5.53
(79.55%)
24.16M

最近閲覧した銘柄

Delayed Upgrade Clock